BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 17671428)

  • 1. Spy1 enhances phosphorylation and degradation of the cell cycle inhibitor p27.
    McAndrew CW; Gastwirt RF; Meyer AN; Porter LA; Donoghue DJ
    Cell Cycle; 2007 Aug; 6(15):1937-45. PubMed ID: 17671428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p27 phosphorylation by Src regulates inhibition of cyclin E-Cdk2.
    Chu I; Sun J; Arnaout A; Kahn H; Hanna W; Narod S; Sun P; Tan CK; Hengst L; Slingerland J
    Cell; 2007 Jan; 128(2):281-94. PubMed ID: 17254967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C-terminal phosphorylation controls the stability and function of p27kip1.
    Kossatz U; Vervoorts J; Nickeleit I; Sundberg HA; Arthur JS; Manns MP; Malek NP
    EMBO J; 2006 Nov; 25(21):5159-70. PubMed ID: 17053782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of cell division by intrinsically unstructured proteins: intrinsic flexibility, modularity, and signaling conduits.
    Galea CA; Wang Y; Sivakolundu SG; Kriwacki RW
    Biochemistry; 2008 Jul; 47(29):7598-609. PubMed ID: 18627125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon-γ-induced p27KIP1 binds to and targets MYC for proteasome-mediated degradation.
    Bahram F; Hydbring P; Tronnersjö S; Zakaria SM; Frings O; Fahlén S; Nilsson H; Goodwin J; von der Lehr N; Su Y; Lüscher B; Castell A; Larsson LG
    Oncotarget; 2016 Jan; 7(3):2837-54. PubMed ID: 26701207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific Conformational Dynamics and Expansion Underpin a Multi-Step Mechanism for Specific Binding of p27 with Cdk2/Cyclin A.
    Tsytlonok M; Hemmen K; Hamilton G; Kolimi N; Felekyan S; Seidel CAM; Tompa P; Sanabria H
    J Mol Biol; 2020 Apr; 432(9):2998-3017. PubMed ID: 32088186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of cold atmospheric microwave plasma (CAMP) on wound healing in canine keratinocytes.
    Lertpatipanpong P; Sillapachaiyaporn C; Oh G; Kang YH; Hwang CY; Baek SJ
    Front Cell Dev Biol; 2023; 11():1105692. PubMed ID: 36760362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stabilization of c-Myc by the atypical cell cycle regulator, Spy1, decreases efficacy of breast cancer treatments.
    Ferraiuolo RM; Fifield BA; Hamm C; Porter LA
    Breast Cancer Res Treat; 2022 Nov; 196(1):17-30. PubMed ID: 36029387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High Spy1 expression predicts poor prognosis in colorectal cancer.
    Jin Q; Liu G; Bao L; Ma Y; Qi H; Yun Z; Dai Y; Zhang S
    Cancer Manag Res; 2018; 10():2757-2765. PubMed ID: 30147372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural basis of divergent cyclin-dependent kinase activation by Spy1/RINGO proteins.
    McGrath DA; Fifield BA; Marceau AH; Tripathi S; Porter LA; Rubin SM
    EMBO J; 2017 Aug; 36(15):2251-2262. PubMed ID: 28666995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cyclin-like protein, SPY1, regulates the ERα and ERK1/2 pathways promoting tamoxifen resistance.
    Ferraiuolo RM; Tubman J; Sinha I; Hamm C; Porter LA
    Oncotarget; 2017 Apr; 8(14):23337-23352. PubMed ID: 28423577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct interactions with both p27 and Cdk2 regulate Spy1-mediated proliferation in vivo and in vitro.
    Al Sorkhy M; Fifield BA; Myers D; Porter LA
    Cell Cycle; 2016; 15(1):128-36. PubMed ID: 26771716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spy1 participates in the proliferation and apoptosis of epithelial ovarian cancer.
    Lu S; Liu R; Su M; Wei Y; Yang S; He S; Wang X; Qiang F; Chen C; Zhao S; Zhang W; Xu P; Mao G
    J Mol Histol; 2016 Feb; 47(1):47-57. PubMed ID: 26644004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spy1 Protein Mediates Phosphorylation and Degradation of SCG10 Protein in Axonal Degeneration.
    Liu Y; Wang Y; Chen Y; Li X; Yang J; Liu Y; Shen A
    J Biol Chem; 2015 May; 290(22):13888-94. PubMed ID: 25869138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The atypical cell cycle regulator Spy1 suppresses differentiation of the neuroblastoma stem cell population.
    Lubanska D; Porter LA
    Oncoscience; 2014; 1(5):336-48. PubMed ID: 25594028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell adhesion to fibronectin down-regulates the expression of Spy1 and contributes to drug resistance in multiple myeloma cells.
    Fei M; Hang Q; Hou S; Ruan C
    Int J Hematol; 2013 Oct; 98(4):446-55. PubMed ID: 24037419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased expression and prognostic role of mitogen-activated protein kinase phosphatase 4 in hepatocellular carcinoma.
    Liu J; Ni W; Xiao M; Jiang F; Ni R
    J Gastrointest Surg; 2013 Apr; 17(4):756-65. PubMed ID: 23325341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temporal-spatial expressions of Spy1 in rat sciatic nerve after crush.
    Cao J; Yang J; Wang Y; Xu J; Zhou Z; Cheng C; Liu X; Cheng X; Long L; Gu X
    Cell Mol Neurobiol; 2013 Mar; 33(2):213-21. PubMed ID: 23129232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of Spy1 protein in human non-Hodgkin's lymphomas is correlated with phosphorylation of p27 Kip1 on Thr187 and cell proliferation.
    Hang Q; Fei M; Hou S; Ni Q; Lu C; Zhang G; Gong P; Guan C; Huang X; He S
    Med Oncol; 2012 Dec; 29(5):3504-14. PubMed ID: 22492278
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.